In the course of autoimmune CNS inflammation, inflammatory infiltrates form characteristic perivascular lymphocyte cuffs by mechanisms that are not yet well understood. Here, intravital two-photon imaging of the brain in anesthetized mice, with experimental autoimmune encephalomyelitis, revealed the highly dynamic nature of perivascular immune cells, refuting suggestions that vessel cuffs are the result of limited lymphocyte motility in the CNS. On the contrary, vessel-associated lymphocyte motility is an actively promoted mechanism which can be blocked by CXCR4 antagonism. In vivo interference with CXCR4 in experimental autoimmune encephalomyelitis disrupted dynamic vessel cuffs and resulted in tissue-invasive migration. CXCR4-mediated perivascular lymphocyte movement along CNS vessels was a key feature of CD4 + T cell subsets in contrast to random motility of CD8 + T cells, indicating a dominant role of the perivascular area primarily for CD4 + T cells. Our results visualize dynamic T cell motility in the CNS and demonstrate differential CXCR4-mediated compartmentalization of CD4 + T-cell motility within the healthy and diseased CNS.
Introduction
The advent of two-photon laser scanning microscopy in immunology has revealed the intricate and sometimes unexpected dynamics of lymphocytes within living thymus, spleen and lymph node, thereby adding important knowledge to our understanding T cells in their effector or effector-memory state in the CNS, which is a target not only for physiologic immune surveillance but also for pathologic autoimmune processes such as experimental autoimmune encephalomyelitis (EAE). Both CD4 + and CD8 + T-cell subsets are present in neuroinflammatory lesions. However, their distinct role and significance in pathogenesis (Gay et al., 1997; Prat and Antel, 2005; Frohman et al., 2006) and in the events leading to efficient immune surveillance or to fatal autoimmunity are surrounded by many question marks. It has been shown that a distinct interplay of chemokines and adhesion molecules initiates a complex adhesion/activation cascade at the CNS vasculature, which leads to rolling and tethering of lymphocytes on the luminal side of the endothelium, and culminates in transmigration across the endothelial lining (Vajkoczy et al., 2001; Engelhardt and Ransohoff, 2005) . The adhesion molecule VLA-4 plays a crucial role in the transmigration process, as interference with a4-integrin binding reduced T-cell entry into the CNS (Engelhardt et al., 1998; Brocke et al., 1999) . However, the role of chemokines and adhesion molecules within the CNS parenchyma after successful transmigration is not clear. Within the CNS, CXCL12, the ligand of CXCR4 has been detected in adult healthy brain tissue as well as in inflammatory lesions of multiple sclerosis patients (Krumbholz et al., 2006) , and also in CNS disease models of vascular and inflammatory diseases (Stumm et al., 2002; McCandless et al., 2006) . Further, CXCL12 expression at the basolateral surface of endothelial cells in the CNS indicates a potential role of this chemokine for immune cells once they have transmigrated the endothelial lining. Following our previous in vitro findings in hippocampal slices, those T cells can in principle traffic through compact CNS tissue (Nitsch et al., 2004) , we investigated the rules guiding the cells in the brain in vivo, which until recently was not thought to be a target of dynamic immune processes. We provide a detailed picture of distinct motility patterns of different T-cell subpopulations in the non-inflamed CNS, and describe deep-tissue inflammation in the brain in vivo.
Materials and Methods
Mice C57BL/6 mice and C57BL/6 pups were purchased from Charles River (Germany); C57BL/6-RAG1 À/À (B6;129 S7-Rag1tm1Mom/J ) were purchased from 'Bundesinstitut fü r Risikobewertung (BFR)'. C57BL/6 LFA-1 À/À mice were kindly provided by M. Baier (Robert-KochInstitut, Berlin); C57BL/6 CCR7 À/À mice (B6.129P2(C)-Ccr7 tm1Rfor /J) were kindly provided by U.E. Hö pken (MDC Berlin-Buch); b-actin-EGFP (acEGFP) transgenic C57BL/6 (C57BL/6-Tg (ACTB-EGFP)1Osb/J ),
OT-1 (C57BL/6-Tg (TcraTcrb)1100Mjb ) and OT-2 mice (C57BL/ 6-Tg (TcraTcrb)425Cbn ) were bred under specifically pathogen free (SPF) conditions at the central animal facility of the Charité -Universitaetsmedizin Berlin (FEM) and kept in-house for experiments in individually ventilated cages (IVC). C57BL/6 CXCR4 +/À mice (B6.129X-Cxcr4 tm1Qma /J) were crossed with b-actin-EGFP at the MDC Berlin-Buch under SPF conditions in IVC. Conventional and mixed bone marrow chimeras were generated as described previously (Kursar et al., 2005; Gutcher et al., 2006) , with the following modifications: recipients were wild-type (WT) C57BL/6; for conventional bone marrow chimera donor cells were derived from b-actin-EGFP C57BL/6, for mixed bone marrow chimera from RAG1 À/À mice and b-actin-EGFP C57BL/6 (5:1 ratio of RAG1 À/À and b-actin-EGFP). In brief, recipient animals were sublethally irradiated with 1100 cGy (split dose 
Experimental Autoimmune Encephalomyelitis
Mice were immunized subcutaneously with 150 mg of MOG (Pepceuticals, UK) emulsified in CFA (BD Difco, Germany). Mice received 200 ng Pertussis toxin (PTx, List Biological Laboratories, Inc.) intraperitoneally at the time of immunization and 48 h later. Mice were checked for clinical symptoms daily, and signs were translated into clinical score as follows: 0 = no detectable signs of EAE; 0.5 = tail weakness; 1 = complete tail paralysis; 2 = partial hind limb paralysis; 2.5 = unilateral complete hind limb paralysis; 3 = complete bilateral hind limb paralysis; 3.5 = complete hind limb paralysis and partial forelimb paralysis; 4 = total paralysis of forelimbs and hind limbs (mice with a score above 3.5 to be killed); 5 = death. In vivo treatment of EAE animals was performed by intraperitoneal injection of 5 mg AMD3100 per mg body weight starting 3 days prior to microscopy.
CNS immune cell isolation and confocal histology
Lethally anaesthetized animals were transcardially perfused with icecold PBS. Brain and spinal cord were isolated, cut into small pieces and diluted in IMDM (Gibco, Germany) substituted with 10 mg/ml Collagenase/Clostridiopeptidase (Sigma, Germany) and 200 U/ml DNAse (Roche, Germany). After incubation for 30 min at 37 C under continuous rotation, the CNS tissue was put through a mesh (70 mm) and mononuclear cells separated by conventional 40/70 Percoll centrifugation. For confocal histology, PBS perfusion was followed by fixation with 4% PFA and sequential cryopreservation in sucrose. Tissue samples were then embedded in optimum cutting temperature (OCT) medium, frozen in liquid nitrogen, sectioned at a thickness of 10 mm and stained with the indicated fluorescently labelled antibody. Confocal images were recorded with an upright laser microscope (Leica DM 2500) equipped with a Â20 objective (oil-immersion NA 0.7) and a Â40 objective (oil-immersion NA 1.15) and sequential scanning. During the processing stage, individual image channels were pseudocoloured with RGB values corresponding to each of the fluorophore emission spectral profiles.
Cell culture
Mice (6-10 weeks old) were sacrificed, and spleen cells were isolated as described (Nogai et al., 2005) . Spleen cells were cultured in 3 Â 10 6 /ml cell culture medium (RPMI 1640 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 10% foetal calf serum), and stimulated with the respective ovalbumin (OVA) peptide (for cells from OT-1 mice 25 nM OVA 257-264 for OT-2 cells 0.3 mM OVA 323-339; Pepceuticals, UK). MACS Õ -sorted splenic
, CCR7 À/À and WT CD4 + T cells were polyclonally stimulated for 3-7 days by plates pre-coated with 3 mg/ml anti-CD3 and 2.5 mg/ml anti-CD28. Differentiation towards a T H 1 phenotype of OT-2 cells was achieved by addition of 2.5 ng/ml IL-12 and 5 mg/ml anti-IL-4 (11B11); for the T H 2-like phenotype of OT-2 cells, 200 U/ml IL-4, 5 mg/ml anti-IL-12 (C17.8) and anti-IFN-(AN18.17.24) were added. Cells were kept in cell culture medium supplemented with hrIL-2 (Chiron Therapeutics) and restimulated every 7 days. Adequate cytokine production was checked on day 4-7 with PMA/ Ionomycin stimulation. T cells were generally taken between days 3 and 7 for co-culture experiments. These T-cell subpopulations showed similar T-cell motility and cytokine patterns. For limiting dilution cultures, MOG 35-55 /CFA/PTx-immunized C57BL/6 were sacrificed between days 40 and 50, and spleen cells isolated as stated above. Bulk cultures of primed CD4 + T cells were generated by stimulation of CD8 + -depleted (MACS Õ ) spleen cells with the cognate antigen at a concentration of 50 mg/ml and 2.5 ng/ml IL-12. Culture cells were harvested on day 8, dead cells removed by Ficoll-gradient centrifugation and 100 cells per well stimulated in 96-well plates in the presence of 100 000 CD90-depleted, syngenic APC (see above) and 50 mg/ml MOG . Cells were incubated for 14 days with regular medium exchange and addition of hrIL-2 (100 U/ml every 2 days). Positive wells were identified microscopically and expanded by regular restimulation with syngenic APC and cognate antigen every week. For VLA-4 blockade, T cells were pre-incubated with 20 mg/ml antia4-integrin (clone R1-2) (Engelhardt et al., 1998; Brocke et al., 1999) for 24 h and subsequently treated as stated above. For CXCR4 blockade, 10 mg/ml AMD3100 was added 3 h before harvesting the cell cultures.
Chemotaxis assays were performed as previously described (Debes et al., 2006) . Briefly, 2 Â 10 5 culture T cells were suspended in 100 ml culture medium and subsequently added to 5-mm pore size, 24-well tissue culture inserts. The lower chamber contained 600 ml culture medium with or without 180 ng/ml CXCL12 (Peprotech, Germany). Cells were incubated for 90 min at 37 C and cell numbers assessed after staining with fluorescent antibodies to CD4 and CD8 on a FACSCalibur by time-restricted measurements. Brain slice culture C57BL/6 p10-p12 pups were lethally anaesthetized, and CNS vessels were revealed by intracardial perfusion with 2% red fluorescent rhodamine-dextran (70 kDa) or green fluorescent FITC-dextran (150 kDa) in PBS. Brains were removed immediately and put into 4 C cold aerated (carbogen, 95% O 2 and 5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 3 mM KCl, 1.6 mM CaCl 2 , 1.8 mM MgSO 4 and 10 mM glucose, adjusted to pH 7.35. 400-mm thick brain slices were cut with a Vibratome (NVSLM1; Motorized Advance Vibroslice). Hippocampal slices were isolated, allowed to recover for at least 1 h at room temperature before transfer to a heated Luigs and Neumann slice chamber (37 C), in which slices were continuously perfused with pre-warmed carbogen-aerated ACSF. T cells were pipetted upon the slice and allowed to enter the slice for about half-an-hour before imaging; image acquisition was usually performed for $5 h per slice. Human neocortical tissue was obtained from patients undergoing surgical treatment of pharmacoresistant temporal lobe epilepsy. All procedures were approved by the local Ethics Committee, carried out in accordance with the Declaration of Helsinki and are described in detail elsewhere (Nitsch et al., 2000; Dorr et al., 2005) . Briefly, after resectioning, brain tissue was immediately transferred in ACSF (4-10 C, equilibrated with 95% O 2 and 5% CO 2 ). Vibratome sections of 400 mm were prepared, stored at room temperature in carbogenequilibrated ACSF, and stained prior to imaging by incubation with FITC-labelled Lycopersicon esculentum (tomato) Lectin. Further preparation was performed analogously to murine slices.
Two-photon laser scanning microscopy Brain slice cultures
Cells were visualized in brain slice cultures by a two-photon system SP2 (Leica, Heidelberg, Germany) equipped with an upright microscope fitted with a Â20 water-immersion objective (NA 0.5; Leica). Fluorescent dyes were excited simultaneously by a mode-locked Ti-sapphire laser (Tsunami; Spectra-Physics) at wavelength 840 nm.
Fluorescence from FITC-dextrane and Celltracker Orange CMTMR (Invitrogen, Germany) were collected using two external nondescanned detectors. Xyz stacks were typically collected 50-150 mm below the surface over a period of 1-2 h (z-stack ranging between 30-and 60 mm thickness, z-plane distance typically 1.8 mm).
In vivo
About 100 ml 2% rhodamine-dextran (70 kDa) in PBS was intravenously injected before mice were anaesthetized using 1.5% isoflurane (Abott) in oxygen/nitrous oxide (2:1) with a facemask. Mice were then tracheotomized and continuously respirated with a Harvard Apparatus Advanced Safety Respirator (Hugo Sachs, Germany). The preparation of the imaging field was performed according to adapted protocols for cortical imaging (Gobel and Helmchen, 2007) . In brief, the brainstem was exposed by carefully removing musculature above dorsal neck area and removing dura mater between first cervical vertebra and occipital skull bone. Head was inclined for access to deeper brainstem regions and the brainstem superfused with isotonic Ringer solution. A sterile agarose patch (0.5 in 0.9% NaCl solution) was installed on the now exposed brain surface to reduce heartbeat and breathing artefacts. During surgery and microscopy body temperature was maintained at 37 C. Anaesthesia depth was controlled by continuous CO 2 measurements of exhaled gas and recorded with a CI-240 Microcapnograph (Columbus Instruments, USA). Typical recording times were up to 7 h.
Data analysis
Image series were postprocessed using MATLAB (Mathworks, Germany). Cell recognition, movement tracking and three-dimesional presentation were performed with Volocity (Improvision, Germany), and tracks with durations 45 min were included in the analysis. Average cell velocity was calculated with Volocity. For angle comparison between cell trajectories and vessel structures, and for vessel distance measurements at the end of the track, cell-tracking data from Volocity was further processed in MATLAB. For each track, a vector between origin and endpoint was calculated in a twodimensional angle, and distance between the cell-tracking vector and the vector representing the vessel was calculated using standard linear algebra. Only movement vectors whose endpoints lay within the projection area of the vessel vector below a maximum distance of 100 mm were included in further analysis. Statistical analysis was carried out with SPSS (SPSS, Germany) and graphical presentation with GraphPad Prism 4 (GraphPad Software, USA). Results are shown as individual data points; in addition, mean AE SEM summarize collective data from all experiments performed. To test for statistical significance of differences between T-cell subpopulations, the non-parametric Mann-Whitney U-test was performed.
Results

Intravital imaging of the CNS of living mice with EAE reveals vessel entrapment of CD4 + T lymphocyte motility
In order to monitor parenchymal T-cell trafficking in the in vivo situation within the CNS, we used intravital two-photon microscopy to record lymphocyte behaviour in the upper cervical spinal cord and the brainstem of healthy and EAE-affected mice. Sublethally irradiated WT C57BL/6 mice were reconstituted with bone marrow cells of transgenic b-actin-EGFP (enhanced green fluorescent protein, acEGFP) mice (acEGFP!WT chimeras), which express EGFP in over 95% of recipient CD45 + haematopoietic cells after engraftment of $8-10 weeks.
In an initial set of experiments with non-immunized anesthetized acEGFP!WT mice 8-10 weeks after transplantation, we detected only low numbers of CD45 + EGFP fluorescent cells in the CNS, which were predominantly located in close proximity to the CNS vasculature [ 2006). The absence of irradiation-induced inflammation in sublethally irradiated animals supports the general applicability of the chimeric system for intravital immune cell studies in the CNS.
To determine parenchymal immune cell interactions in neuroinflammation in vivo, we induced active EAE in acEGFP!WT mice and performed two-photon microscopy of the lower brainstem at a depth of 50-150 mm in high-score EAE mice. At the peak of disease, the majority of invading cells had successfully transmigrated, which allowed us to visualize the behaviour of immune cells in their intraparenchymal phase. We observed a complex picture of morphologically and dynamically diverse invading CD45 + EGFP cells (Fig. 1A and Supplementary Video 2).
Strikingly, the majority of CD45 + EGFP cells demonstrated vesselassociated motility, which resulted in alignment of cell paths predominantly along medium-sized parenchymal veins (diameter 25-50 mm) (Fig. 1A, lower EGFP T cells and induced active EAE after 4 weeks of homoeostatic engraftment. In line with the chimeric model, we found in these non-irradiated animals a strong vessel association of CD4 + T-cell motility. The motility pattern of CD4 + EGFP T cells was characterized as loose alignment without one-way directionality, resulting in a seesaw motility pattern of CD4 + EGFP T-cell tracks ( Fig. 1C and Supplementary Video 3). These findings raised the question of whether the capacity of CD4 + T cells to enter the CNS parenchyma was reduced or whether these cells were held back by an actively promoted vessel association.
Mechanisms of vessel-associated CD4 + T lymphocyte movement in the non-inflamed murine and human CNS In order to dissect the mechanisms of CNS CD4 + T-cell motility,
we made use of our T cell CNS-slice co-culture model (Nitsch et al., 2004) . In this system, in vitro differentiated ovalbumin (OVA) -specific and myelin-specific CD4 + T-cell subpopulations and OVA-specific CD8 + T cells were co-incubated with brain tissue cultured in artificial cerebrospinal fluid (ACSF). These CNS slices have been shown to retain a middle layer, which consists of intact in vivo like CNS both in murine and human brain cultures (Nitsch et al., 2000) . T cells were labelled with the orange celltracker CMTMR and consecutively coincubated with a living brain slice in which the vasculature had been highlighted by injection of FITC-dextran. After an initial invasion period, in which the potential of tissue penetration was evident, the majority of CD4 + T cells assembled around medium-sized CNS vessels, as shown exemplarily for OT-2 CD4 + T H 1 cells ( Fig. 2A) . Once in the vicinity of a vessel, MOG CD4 + T H 1 cells, OT-2 CD4 + T H 1 and T H 2 cells exhibited a strong vessel association with constant movement tangential to the outer vessel wall. The cells moved up and down the vessel lining, sometimes turning sharply, which led to an abrupt and complete shift in direction. This seesaw movement persisted over the whole imaging period, and was characterized as close crawling of the leading edge along the vessel with the uropod trailing behind ( Fig. 2C and Supplementary Video 4) . The main features of our findings in the mouse model were also found in the analysis of human CD4 + T cell movement. CNS tissue from epilepsy surgery, cultured in ACSF (Nitsch et al., 2000) , was coincubated with polyclonally (plate-bound anti-CD3, anti-CD28) stimulated PBMC (peripheral blood-derived mononuclear cells) from the same donor (Fig. 2D) . We observed CD4 + T cells dexterously moving along the outer vessel wall, the leading edge scanning the outer vessel wall and trailing a uropod (Supplementary Video 5).
To determine whether there was variability in T lymphocyte trafficking, we conducted analogous experiments as for the OT-2 and MOG-specific CD4 + T cells in the murine brain slice co-culture with activated OT-1 CD8 + T cells. Here, we observed striking differences in comparison with the OT-2 and MOG CD4 + T H 1 as well as OT-2 CD4 + T H 2 cells. OT-1 cells rapidly entered the brain parenchyma and showed highly dynamic trafficking through compact CNS tissue ( Fig. 2E and Supplementary Video 6). The migration paths were not restricted to the vessels and no T cell arrest was observed, indicating that-in the absence of the respective antigen-no stable interactions occurred for these highly activated OT-1 CD8 + T cells. The majority of OT-1 CD8 + T cells featured a highly polarized shape with a leading edge and a long uropod being dragged behind, in keeping with movement of OT-1 CD8 + T cells in the lymph node (Hugues et al., 2004) .
Quantification of vessel association could not be achieved with frequently used motility parameters such as mean displacement plot, meandering index or absolute displacement , as all these measures have been developed to describe the most frequent motility patterns in the lymph node, namely 'random trafficking', 'directed migration' or 'confinement'. To objectify the CD4 + and CD8 + CNS motility pattern, we analysed the trajectory vectors, which are the connecting line between starting point and end point of each track (Fig. 3A-D) , and which represent the direction of displacement of individual cells (Hauser et al., 2007) . Next, we mirrored the vectors onto the vessel axis and calculated the smallest angle between vector and vessel, which resulted in a nominal value between 0 and 90 for each track (Fig. 3E ). This measure is independent of polarized directionality and absolute displacement, making it useable as a tool for describing tangential movement along an axis. Accordingly, we observed an alignment of MOG and OT-2 CD4 + T-cell trajectories along the vessel axis. This alignment resulted in acute angles of significantly 545 between the axis and the trajectory vector (32.36 AE 2.56 ), which is in clear contrast to the OT-1 CD8 + T-cell population ( Fig. 3F , P = 0.001). The latter displays widely distributed trajectory vectors in addition to widely distributed vector-vessel angles, resulting in a mean vectorvessel angle approaching 45 (44.96 AE 2.37 ). Thus, we were able to distinguish typical CD8 + T cell movement from CD4 + T cell movement by determining the angle between individual trajectory vector and the nearest vessel through a comparison of the mean vector-vessel angles. Unlike the more invasive CD8 + T cells, all CD4 + T-cell subsets examined here showed vesselassociated movement. This effect was independent of vascular transmigration, as cells in the T-cell-brain slice co-culture model entered the CNS tissue from the parenchymal side and not through the vessels. Further, it was independent of antigen-presentation/ recognition, since MHC mismatch has no effect on the distribution of myelin versus OVA-specific T cells in CNS slices (Nitsch et al., 2004) . These findings led us to postulate a general mechanism of vessel-homing in CD4 + T-cell trafficking within the CNS.
CXCR4 blockade disrupts migration of CD4 + T cells along CNS vessels in non-inflamed CNS tissue and in living EAE mice
To check for involvement of adhesion molecules in lymphocyte CNS trafficking, we investigated polyclonally stimulated CD4 + T H 1 cells derived from LFA1 À/À C57BL/6 and OT-2 CD4 + T H 1 cells after 24-h incubation with an anti-a4-integrin blocking antibody, which has been shown to prevent EAE symptoms by compromising lymphocyte entry into the CNS (Yednock et al., 1992; Engelhardt et al., 1998; Brocke et al., 1999) . To check for the influence of chemokine receptor function, we generated CD4 + T H 1 cells from CCR7 À/À spleen cells; as CXCR4 À/À mice are perinatally lethal, we used incubation with the selective small molecule antagonist AMD3100 for 3 h before experimentation to interfere with CXCR4. While CCR7 deficiency had no influence on the motility pattern, we observed a strikingly different motility pattern in the AMD3100-treated CD4 + T cells, which almost equalled the random-like motility observed in OT-1 cells (Fig. 4A and B and Supplementary Video 7). While the velocities of these cell groups were not changed dramatically (LFA1 À/À 0.087 AE 0.004 mm/s;
anti-VLA-4 0.099 AE 0.007 mm/s; AMD3100 0.074 AE 0.003 mm/s; CCR7 À/À 0.094 AE 0.002 mm/s; Fig. 4C (Fig. 4D) , whereas AMD3100-treatment increased the mean vector-vessel angle-the marker for vessel-associated movement. We found a significant change in the vessel-associated motility with a vector-vessel angle of 42.36 AE 1.99 (P = 0.004, Fig. 4E ) for AMD3100-treated OT-2 CD4 + T H 1 cells and of 43.07 AE 2.67 (P = 0.012, Fig. 4E ) for AMD3100-treated CD4 + CCR7 À/À cells.
In vivo, when we pretreated acEGFP + Rag1 À/À !WT mixed bone marrow chimera (only lymphocytes carry EGFP, see M&M) with the CXCR4 antagonist AMD3100 once daily for at least 3 days prior to intravital microscopy, we observed a shift of cells from a perivascular motility pattern to intraparenchymal infiltration, resulting in disruption of vessel cuffs (Fig. 5A) . Analogously, we observed a disruption of perivascular immune cell motility in CXCR4 À/À foetal-liver chimera (0.076 AE 0.001 mm/s) was similar ( Fig. 5C ), there was a significant difference of both conditions compared with controls in terms of perivascular conformation of immune cells. In the animals in which CXCR4 was blocked or absent, we observed a marked detachment of the immune cells from the vessels. CD45 + EGFP lymphocytes had a mean distance from the vessel wall at the end of the track of 17.89 AE 1.61 mm in the control versus 25.8 AE 1.33 mm in AMD3100-treated mice (Fig. 5D, P50 .001) and 45.28 AE 1.0 mm in CXCR4
À/À mice. Importantly, in the AMD3100-treated and CXCR4 knockout animals, the majority of immune cells in the intraparenchymal area of the imaging field showed randomlike movement, strongly contrasting with the vessel-centred movement pattern observed in untreated/WT littermate EAE score-matched controls. This difference was objectified with the vector-vessel angle analogously to T-cell behaviour in the CNS slice co-culture. AMD3100-treated acEGFP + Rag1 By contrast, vehicle-treated/WT control animals showed increased numbers of smaller vector-vessel angles, resulting in a reduced mean vector-vessel angle of 39.14 AE 1.45 ( role in the transmigration step, in which integrin-mediated adhesion is necessary to overcome endothelial barriers. In the absence of shear stress, matrix-bound chemokines tend to promote lymphocyte movement but not stopping and adhesion, as seen intravascularly during transmigration (Woolf et al., 2007) . Our findings are in keeping with recent reports that integrins and adhesion molecules are not necessary for flowing and squeezing of leukocytes in a three-dimensional environment and in lymph nodes in vivo (Lammermann et al., 2008) .
In the lymph node, random-like motility is the most frequently observed feature of different cell populations. However, this seemingly non-directed motility is in the lymph nodes guided on rails, namely the fibroblastic reticular cells (FRC), which form tight networks in secondary lymphoid organs and which are covered by chemokines (Germain et al., 2008) . It is not known if an FRC comparable structure exists in the CNS. Our data prove that activated T lymphocytes are able to move in a similar way in the CNS as in the lymph node, which suggests that there might be analogous stromal structures which have the same function as FRC in the lymph node (Germain et al., 2008) .
The defining element of intraparenchymal chemokine-mediated lymphocyte compartmentalization consists in the entrapment of free dynamic motility within a defined space, which seemingly lacks anatomical barriers. This phenomenon can be explained by compartmentalizing chemokinesis. The combinatorial control of immune cell motility was previously shown for neutrophils in an in vitro agarose matrix assay, which revealed basic mechanisms of hierarchical chemoattractant gradients (Foxman et al., 1997) . If chemokine-attracted cells come close to the source of the primary chemotactic cue, chemokine concentration will exceed the saturation level of the respective receptors at some point, which then leads to 'disorientation'. This implies a lack of further targeted motility to the primary cue, but also the potential to react to a second stimulus, which can redirect migration within this area. In the absence of a second stimulus there will be undirected free but channelled migration within this zone of saturated chemokine concentration. Figuratively, the chemokine gradient is the gravitational force that keeps the cell in its orbit.
Lymph node T-cell trafficking and correct intranodal compartmentalization are impaired in animals deficient in the ligands of the lymph node homing receptor CCR7, which are abundantly expressed in WT animals in T cell-relevant sites of lymphatic organs (Okada and Cyster 2007; Worbs et al., 2007) . Within the CNS CCR7 appears not to influence local T-cell trafficking along the vessels and thus not to contribute to perivascular immune compartmentalization, since in CNS slices we observed the same migration pattern for CCR7 À/À T cells as for WT controls. When CXCR4 was blocked or absent in vivo, we found a major disturbance of activity pattern, which resulted in a more even distribution of invading CD45 + (mainly CD4 + ) lymphocytes and a disruption of vessel-associated motility. Thus, our data explain previous observations of increased T-cell infiltration upon AMD3100-treatment in EAE (McCandless et al., 2006) . McCandless et al., could show that blockade of CXCR4 with the small molecule antagonist AMD3100 worsened the disease course in MOG-induced active EAE of C57BL/6 mice by increased lymphocyte tissue infiltration. Kohler et al. blocked CXCR4 by application of an antagonistic CXCL12 mutant in the PLP (proteolipid-protein)-induced SJL mouse model (Kohler et al., 2008) . Here, there was a decreased disease severity in active EAE but not in the adoptive transfer of the disease, which indicates an effect on the generation of encephalitogenic T cells in the priming phase in this model and not on the effector phase as in McCandless' study. We speculate that the different nature of blocking agents (AMD3100 versus CXCL12 analogue) might be the source of the observed different outcome of clinical EAE. Recently, Meiron et al. showed that the therapeutic application of a CXCL12 fusion protein leads to IL-10 dependent suppression of EAE by antigen-specific regulatory T cells (Meiron et al., 2008) .
Clearly, CXCR4 channels CD4 + T-cell motility in the perivascular area. Within this compartment, the lymphocytes can interact with each other and/or other immune cells as a prerequisite for the sequential steps involved in the process of inflammation and immune regulation. Lymphocyte accumulation at this site has a physiological role for immune surveillance in the CNS (Hickey and Kimura, 1988; Smorodchenko et al., 2007) . Furthermore, the interaction of encephalitogenic CD4 + T cells with dendritic cells within the perivascular area is crucial for patterning immune responses in the CNS (Greter et al., 2005) . Our data indicate that the segregation of CD4 + T-cell motility is actively promoted, and that it might facilitate an efficient and rapid screening of the mainly perivascular professional antigen-presenting cells (Serafini et al., 2000 (Serafini et al., , 2006 , integrating relevant stimulatory, costimulatory and regulatory signals. Under conditions found at the peak and chronic phase of EAE, further chemokines may contribute to this effect, since also the absence of CXCR3 has been shown to influence T-cell distribution and plaque formation in these disease stages (Muller et al., 2007) . Collectively, these findings support the idea that compartmentalization of activated CD4 + T lymphocytes in the target organ serves a similar purpose as in lymph nodes, i.e. increasing the chance of T-cell receptor and co-receptor engagement with the whole spectrum of possible outcomes between tolerance and immunity. We assume that antigen recognition will be a major but not the only event occurring downstream of CXCL12-induced compartmentalization in both healthy and diseased CNS tissue.
Supplementary material
Supplementary material is available at Brain online.
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